Carsten Henneges

Eli Lilly (Germany)

Papers

2

Total Citations

52

H-Index

2

About

Carsten Henneges is a biostatistician whose work sits at the intersection of clinical trial design and urological outcomes, with a particular focus on post-surgical recovery. His research centers on developing and applying advanced statistical models—especially exploratory decision-tree analyses—to predict patient responses in complex clinical settings. Henneges made significant contributions to the landmark REACTT trial, a multicenter, randomized, double-blind study investigating tadalafil versus placebo for erectile function recovery after bilateral nerve-sparing radical prostatectomy. His pre-specified and exploratory analyses, published in leading urology journals, examined how surgical approach influences recovery trajectories, providing surgeons with data-driven insights to optimize patient counseling. While his most-cited papers have accumulated over 50 citations collectively, their true impact lies in shaping evidence-based postoperative care. Henneges’ methodological rigor—combining robust trial design with innovative predictive modeling—has helped bridge the gap between raw clinical data and actionable treatment strategies, making him a key figure in the statistical underpinnings of modern urological oncology research.

Research Focus

Key Achievements

2
H-Index
2
Papers
52
Total Citations
26
Avg Citations/Paper
🏆 Most Cited Paper
Exploratory Decision-Tree Modeling of Data from the Randomized REACTT Trial of Tadalafil Versus Placebo to Predict Recovery of Erectile Function After Bilateral Nerve-Sparing Radical Prostatectomy
28 citations · 2016
📈 Most Prolific Year: 2016 (1 Papers)
🤝 Key Collaborators: 16
🏛 Institutions: Eli Lilly (Germany)

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago